Kamato D - Search Results

1

Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies.

Kamato D, Ilyas I, Xu S, Little PJ. Kamato D, et al. Int J Mol Sci. 2022 Oct 26;23(21):12964. doi: 10.3390/ijms232112964. Int J Mol Sci. 2022. PMID: 36361754 Free PMC article. Review.

2

Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics.

Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ, Kamato D, Sahebkar A, Wu W, Weng J, Xu S. Liu Z, et al. Among authors: kamato d. Theranostics. 2021 Mar 4;11(9):4502-4515. doi: 10.7150/thno.54498. eCollection 2021. Theranostics. 2021. PMID: 33754074 Free PMC article. Review.

3

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.

Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J. Xu S, et al. Among authors: kamato d. Pharmacol Rev. 2021 Jul;73(3):924-967. doi: 10.1124/pharmrev.120.000096. Pharmacol Rev. 2021. PMID: 34088867 Review.

4

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential.

Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J, Xu S. Ma X, et al. Among authors: kamato d. Int J Biol Sci. 2021 May 11;17(8):2050-2068. doi: 10.7150/ijbs.59965. eCollection 2021. Int J Biol Sci. 2021. PMID: 34131405 Free PMC article. Review.

5

Mouse models of atherosclerosis in translational research.

Ilyas I, Little PJ, Liu Z, Xu Y, Kamato D, Berk BC, Weng J, Xu S. Ilyas I, et al. Among authors: kamato d. Trends Pharmacol Sci. 2022 Nov;43(11):920-939. doi: 10.1016/j.tips.2022.06.009. Epub 2022 Jul 25. Trends Pharmacol Sci. 2022. PMID: 35902281 Review.

6

Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells.

Kamato D, Gabr M, Kumarapperuma H, Chia ZJ, Zheng W, Xu S, Osman N, Little PJ. Kamato D, et al. Int J Mol Sci. 2022 Nov 20;23(22):14425. doi: 10.3390/ijms232214425. Int J Mol Sci. 2022. PMID: 36430902 Free PMC article.

7

Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis.

Afroz R, Cao Y, Rostam MA, Ta H, Xu S, Zheng W, Osman N, Kamato D, Little PJ. Afroz R, et al. Among authors: kamato d. Pharmacol Ther. 2018 Jul;187:88-97. doi: 10.1016/j.pharmthera.2018.02.005. Epub 2018 Feb 15. Pharmacol Ther. 2018. PMID: 29454855 Review.

8

Endothelial function and dysfunction: Impact of metformin.

Nafisa A, Gray SG, Cao Y, Wang T, Xu S, Wattoo FH, Barras M, Cohen N, Kamato D, Little PJ. Nafisa A, et al. Among authors: kamato d. Pharmacol Ther. 2018 Dec;192:150-162. doi: 10.1016/j.pharmthera.2018.07.007. Epub 2018 Jul 27. Pharmacol Ther. 2018. PMID: 30056057 Review.

9

Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Xu S, Kamato D, Little PJ, Nakagawa S, Pelisek J, Jin ZG. Xu S, et al. Among authors: kamato d. Pharmacol Ther. 2019 Apr;196:15-43. doi: 10.1016/j.pharmthera.2018.11.003. Epub 2018 Nov 13. Pharmacol Ther. 2019. PMID: 30439455 Free PMC article.

10

Treatment of atherosclerotic plaque: perspectives on theranostics.

Zhang Y, Koradia A, Kamato D, Popat A, Little PJ, Ta HT. Zhang Y, et al. Among authors: kamato d. J Pharm Pharmacol. 2019 Jul;71(7):1029-1043. doi: 10.1111/jphp.13092. Epub 2019 Apr 25. J Pharm Pharmacol. 2019. PMID: 31025381 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page